Publications by authors named "S Vuddagiri"

Claim this Profile
F
Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors.
Pearly Shuyi Ng, Klement Foo, Sandra Sim, Gang Wang, Chuhui Huang, Susmitha Vuddagiri

Bioorg Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3".
Chuhui Huang, Si Si Liew, Grace R Lin, Anders Poulsen, Melgious J Y Ang, Susmitha Vuddagiri

ACS Med Chem Lett· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3.
Chuhui Huang, Si Si Liew, Grace R Lin, Anders Poulsen, Melgious J Y Ang, Susmitha Vuddagiri

ACS Med Chem Lett· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia.
Haiyan Yang, Lohitha Rao Chennamaneni, Melvyn Wai Tuck Ho, Shi Hua Ang, Eldwin Sum Wai Tan, Susmitha Vuddagiri

J Med Chem· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microcapsules engineered to support mesenchymal stem cell (MSC) survival and proliferation enable long-term retention of MSCs in infarcted myocardium.
Anna Blocki, Sebastian Beyer, Jean-Yves Dewavrin, Anna Goralczyk, Yingting Wang, Susmitha Vuddagiri

Biomaterials· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis